http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101062616-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 |
filingDate | 2009-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101062616-B1 |
titleOfInvention | Anti-aging pharmaceutical composition containing epipriedellanol as an active ingredient |
abstract | The present invention relates to a pharmaceutical composition for inhibiting aging containing one or two or more of a terpene-based compound or catechin glycoside-based compound isolated from Salicis radicis cortex, in particular epipriedelanol Inhibits cellular senescence by adriamycin and inhibits p53 protein expression, which increases expression in these cellular aging processes, such as skin aging, rheumatoid arthritis, osteoarthritis, hepatitis, chronic skin damage tissue, arteries It can be usefully used to treat diseases such as sclerosis, prostate hyperplasia and liver cancer.n n n n Adenocarp, Epipriedellanol, Adriamycin, Aging |
priorityDate | 2009-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 288.